. "Appendix A: Publc Health Consquences of Use of Antimicrobial Agents in Agriculture." The Resistance Phenomenon in Microbes and Infectious Disease Vectors: Implications for Human Health and Strategies for Containment -- Workshop Summary. Washington, DC: The National Academies Press, 2003.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Sorensen TL, Wegener HC, Frimodt-Moller N. 2002. [Letter] Resistant bacteria in retail meats and antimicrobial use in animals. New England Journal of Medicine346:777– 779.
Spika JS, Waterman SH, Hoo GW, St Louis ME, Pacer RE, James SM, Bissett ML, Mayer LW, Chiu JY, Hall B, et al. 1987. Chloramphenicol-resistant Salmonella Newport traced through hamburger to dairy farms. New England Journal of Medicine316:565–570.
Tauxe R. 1992. Epidemiology of Campylobacter jejuni infections in the United States and other industrialized nations. In: Nanchamkin I, Blaser MJ, Tompkins LS, eds. Campylobacter jejuni: Current Status and Future Trends.Washington, DC: American Society for Microbiology Press. Pp. 9–19.
Tauxe RV, Cavanagh TR, Cohen ML. 1989. Interspecies gene transfer in vivo producing an outbreak of multiply resistant shigellosis. Journal of Infectious Diseases160:1067–1070.
van den Bogaard AE and Stobberingh EE. 1999. Antibiotic usage in animals: impact on bacterial resistance and public health. Drugs58:589–607.
van den Bogaard AE, Bruinsma N, Stobberingh EE. 2000a. The effect of banning avoparcin on VRE carriage in the Netherlands. Journal of Antimicrobial Chemotherapy46:146– 147.
van den Bogaard AE, London N, Stobberingh EE. 2000b. Antimicrobial resistance in pig faecal samples from The Netherlands (five abattoirs) and Sweden. Journal of Antimicro bial Chemotherapy45:663–671.
Wegener HC, Aarestrup FM, Jensen LB, Hammerum AM, Bager F. 1999. Use of antimicrobial growth promoters in food animals and Enterococcus faecium resistance to therapeutic antimicrobial drugs in Europe. Emerging Infectious Diseases5:329–335.
WHO (World Health Organization). 1997. The Medical Impact of the Use of Antimicrobials in Food Animals: Report and Proceedings of a WHO Meeting. Berlin, October 13–17, 1997. Geneva: WHO.
WHO. 1999. Containing Antimicrobial Resistance: Review of the Literature and Report of a WHO Workshop on the Development of a Global Strategy for the Containment of Antimicrobial Resistance.Geneva, February 4–5, 1999. Geneva: WHO.
WHO. 2000. WHO Global Principles for the Containment of Antimicrobial Resistance in Animals Intended for Food: Report of a WHO Consultation.Geneva, Switzerland, June 5-9, 2000. Geneva: WHO.
Wierup M. 1998. Preventive methods replace antibiotic growth promoters: ten years experience from Sweden. APUA Newsletter16:1–4.
Winokur PL, Brueggemann A, DeSalvo DL, Hoffmann L, Apley MD, Uhlenhopp EK, Pfaller MA, Doern GV. 2000. Animal and human multidrug-resistant, cephalosporin-resistant Salmonella isolates expressing a plasmid-mediated CMY-2 AmpC beta-lactamase. Anti microbial Agents and Chemotherapy44:2777–2783.
Winokur PL, Vonstein DL, Hoffman LJ, Uhlenhopp EK, Doern GV. 2001. Evidence for transfer of CMY-2 AmpC ß-lactamase plasmids between Escherichia coli and Salmonella isolates from food animals and humans. Antimicrobial Agents and Chemotherapy 45:2716–2722.
Witte W. 1998. Medical consequences of antibiotic use in agriculture. Science279:996–997.